Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-16 | SpringWorks Therapeutics, Inc. | Pichl Daniel
(Chief People Officer) |
S | Common Stock | D | 15000 | $50.10 - $50.10 | $751,549 |
| 2024-02-16 | SpringWorks Therapeutics, Inc. | Pichl Daniel
(Chief People Officer) |
M | Common Stock | A | 15000 | $27.64 - $27.64 | $414,600 |
| 2024-02-02 | SpringWorks Therapeutics, Inc. | Ashar Bhavesh
(Chief Commercial Officer) |
S | Common Stock | D | 8056 | $43.75 - $49.32 | $381,407 |
| 2024-02-02 | SpringWorks Therapeutics, Inc. | Pichl Daniel
(Chief People Officer) |
S | Common Stock | D | 26181 | $43.81 - $46.44 | $1,160,360 |
| 2024-02-02 | SpringWorks Therapeutics, Inc. | Pichl Daniel
(Chief People Officer) |
M | Common Stock | A | 16250 | $27.64 - $27.64 | $449,150 |
| 2024-01-05 | SpringWorks Therapeutics, Inc. | Weinstein Herschel S
(General Counsel & Secretary) |
F | Common Stock | D | 4747 | $37.96 - $41.53 | $188,846 |
| 2024-01-04 | SpringWorks Therapeutics, Inc. | Weinstein Herschel S
(General Counsel & Secretary) |
A | Common Stock | A | 21156 | $0.00 - $0.00 | $0 |
| 2024-01-05 | SpringWorks Therapeutics, Inc. | Smith L. Mary
(Chief Development Officer) |
F | Common Stock | D | 5732 | $37.96 - $41.53 | $230,206 |
| 2024-01-04 | SpringWorks Therapeutics, Inc. | Smith L. Mary
(Chief Development Officer) |
A | Common Stock | A | 21156 | $0.00 - $0.00 | $0 |
| 2024-01-05 | SpringWorks Therapeutics, Inc. | Islam Saqib
(Chief Executive Officer) |
F | Common Stock | D | 30789 | $37.96 - $41.53 | $1,232,667 |
| 2024-01-04 | SpringWorks Therapeutics, Inc. | Islam Saqib
(Chief Executive Officer) |
A | Common Stock | A | 88000 | $0.00 - $0.00 | $0 |
| 2024-01-05 | SpringWorks Therapeutics, Inc. | Pichl Daniel
(Chief People Officer) |
F | Common Stock | D | 2979 | $37.96 - $41.53 | $118,098 |
| 2024-01-04 | SpringWorks Therapeutics, Inc. | Pichl Daniel
(Chief People Officer) |
A | Common Stock | A | 22919 | $0.00 - $0.00 | $0 |
| 2024-01-05 | SpringWorks Therapeutics, Inc. | Perier Francis I Jr
(Chief Financial Officer) |
F | Common Stock | D | 5366 | $37.96 - $41.53 | $215,169 |
| 2024-01-04 | SpringWorks Therapeutics, Inc. | Perier Francis I Jr
(Chief Financial Officer) |
A | Common Stock | A | 21156 | $0.00 - $0.00 | $0 |
| 2024-01-05 | SpringWorks Therapeutics, Inc. | Nofi Michael
(Chief Accounting Officer) |
F | Common Stock | D | 2232 | $37.96 - $41.53 | $88,521 |
| 2024-01-04 | SpringWorks Therapeutics, Inc. | Nofi Michael
(Chief Accounting Officer) |
A | Common Stock | A | 14104 | $0.00 - $0.00 | $0 |
| 2024-01-05 | SpringWorks Therapeutics, Inc. | Edris Badreddin
(Chief Operating Officer) |
F | Common Stock | D | 9935 | $37.96 - $41.53 | $396,645 |
| 2024-01-04 | SpringWorks Therapeutics, Inc. | Edris Badreddin
(Chief Operating Officer) |
A | Common Stock | A | 42312 | $0.00 - $0.00 | $0 |
| 2024-01-05 | SpringWorks Therapeutics, Inc. | Cassidy James
(Chief Medical Officer) |
F | Common Stock | D | 3450 | $37.96 - $41.53 | $134,863 |
| 2024-01-04 | SpringWorks Therapeutics, Inc. | Cassidy James
(Chief Medical Officer) |
A | Common Stock | A | 28208 | $0.00 - $0.00 | $0 |
| 2024-01-05 | SpringWorks Therapeutics, Inc. | Ashar Bhavesh
(Chief Commercial Officer) |
F | Common Stock | D | 3956 | $37.96 - $41.53 | $155,341 |
| 2024-01-04 | SpringWorks Therapeutics, Inc. | Ashar Bhavesh
(Chief Commercial Officer) |
A | Common Stock | A | 26445 | $0.00 - $0.00 | $0 |
| 2023-11-30 | SpringWorks Therapeutics, Inc. | Islam Saqib
(Chief Executive Officer) |
A | Common Stock | A | 199053 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |